Ivermectin Pädia Gmbh (Ivermectin)

Ivermectin binds to glutamate‑gated chloride channels that are present in many invertebrates. This binding opens the channels, allowing an influx of chloride ions, which hyperpolarizes the cell membrane, causing paralysis and eventual death of the parasite while sparing human cells.

The specific dose of Ivermectin Pädia Gmbh is determined by the prescribing healthcare professional based on the patient’s age, weight, the indication being treated and local treatment guidelines. Only a qualified prescriber should set the dosing regimen.

Safety data for ivermectin in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Use is generally avoided unless the potential benefit justifies the potential risk, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ivermectin belongs to the macrocyclic lactone class and offers a broad spectrum against several nematodes and ectoparasites. Compared with older agents such as albendazole or topical permethrin, ivermectin provides a convenient oral route and often requires fewer doses, though choice depends on the specific infection and patient factors.

Ivermectin Pädia Gmbh should be stored at room temperature, below 25 °C, in its original packaging. The container should be kept tightly closed, protected from moisture and direct sunlight to maintain product stability.

The medication is taken orally, usually as a single dose or a short course depending on the indication. It may be swallowed with water and can be taken with or without food, unless the prescribing clinician advises otherwise.

Serious adverse events, although rare, include severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, visual disturbances, seizures and anaphylaxis. Patients should seek immediate medical attention if they experience any of these symptoms after taking the drug.

Ivermectin should not be used by individuals with a known hypersensitivity to the drug or its excipients. Caution is also advised for patients with severe liver disease, certain central nervous system disorders, or those taking medications that strongly interact with ivermectin.